GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy

$718,598
Daniel B Stetson · University Of Washington · R01 · FY2022 · CA

LIGHT-ACTIVATED GENE EXPRESSION IN SINGLE CELLS WITHIN TISSUE

$718,099
Robert H Singer · Albert Einstein College Of Medicine · R01 · FY2009 · GM

Project 1: Physical modeling and dynamics of tumor cell migration mechanics

$717,814
David J Odde · University Of Minnesota · U54 · FY2017 · CA

Dissecting the impact of tumor-intrinsic chromosomal instability on the cancer ecosystem

$717,795
Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA

Artificial intelligence enabled Stroma-Weighted Automated Grading system to improve risk stratification in Black Men

$717,667
Ashutosh K Tewari · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma

$717,369
Mark Yarchoan · Johns Hopkins University · R01 · FY2025 · CA

Therapeutic Targeting of RNA Splicing in Triple-Negative Breast Cancer

$717,288
Thomas Westbrook · Baylor College Of Medicine · R01 · FY2023 · CA

Vermont Breast Cancer Molecular Characterization Laboratory

$717,240
Janet L Stein · University Of Vermont & St Agric College · U01 · FY2015 · CA

Nuclear Structure and Gene Expression

$717,227
Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2012 · CA

Personalized Adoptive T-cell Therapy for AML

$717,103
David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA

The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene

$716,818
Dan Mercola · University Of California-Irvine · U01 · FY2013 · CA

Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors

$716,793
Christopher C. Derenzo · St. Jude Children'S Research Hospital · R01 · FY2024 · CA

A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers

$716,756
Nancy Y Lee · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers

$716,756
Nancy Y Lee · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Cancer Stem Cells in Cholangiocarcinoma

$716,564
Changqing Xie · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Molecular Analysis of Breast Cancer Metastasis to the Brain

$716,369
Patricia Schriver Steeg · Basic Sciences · Z01 · FY2007 · CA

Mechanisms of Tumor Cell Dormancy and Tumor Recurrence

$716,309
Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Ultrasensitive detection of circulating DNA methylation for head and neck cancer prognosis

$716,123
Christine H Chung · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · DE

In Vivo Multiphoton Based Imaging of Complex Cancer Cell Behavior

$716,068
Vladislav Verkhusha · Albert Einstein College Of Medicine · R01 · FY2013 · CA

Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia

$715,641
Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA

A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events

$715,543
Adam Mor · Columbia University Health Sciences · R01 · FY2025 · AI

Clinical trials employing cancer vaccine combination therapies

$715,531
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Role of IKK alpha in lung cancer development

$715,207
Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis

$715,207
Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Using implantable microdevices for deep phenotyping of multiple drug responses in brain tumor patients

$714,942
Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2025 · CA